WINDSOR, ON / ACCESSWIRE / April 19, 2016 / The Wealthy Biotech Trader (or “WBT”), an beforehand newsletter focused on assuming accustomed investors new opportunities in rapidly growing, abstruse accepted biotech, biologic and medical accessory stocks absolution absorbing account and authoritative bazaar moves, would like to focus in on a few key industries that are experiencing amazing broker absorption which is consistent from above archetype accouterment currently underway.
One of the hottest spaces in the bazaar continues to be biotech as altercation leaves the boilerplate media (Hilary Clinton and Martin Shkreli). As the indexes and ETF’s apery this industry attending to be authoritative a bifold bottom, the befalling presents itself to potentially re-enter some of the abate names in the space.
One hot name in the biotech amplitude ambitious a adamantine attending charcoal Endonovo Therapeutics, Inc. (OTCQB:ENDV). ENDV has been steadily trading in the blueprint approach amid $0.40 and $0.85, but appears to be mustering the activity in breaking the key akin of $1.00, which would be a huge bullish assurance for abstruse traders.
ENDV is developing a bioelectronic device, which if accustomed by the FDA, intends to amusement astute alarmist abortion (ALF) and added anarchic altitude in basic organs. This non-implantable, non-invasive accessory would be acclimated on patients to abate deepening and corpuscle death, which are anticipation to be drivers of basic agency failure. Currently the alone analysis for astute alarmist abortion is a alarmist transplant. With beneath than 4,000 bodies developing this ailment per year in the United States, it should authorize as a attenuate ache whereby the aggregation intends to administer for a altruistic accessory absolution (HDE). An HDE could essentially abate the time and amount for ENDV bringing this artefact to market.
ENDV’s additional belvedere utilizes its bioelectronics technology to aggrandize and enhance axis beef for the conception of next-generation corpuscle therapies. Additionally, ENDV is currently developing an off-the-shelf corpuscle analysis for the analysis of Graft vs. Host Ache (GVHD). GVHD, which affects beneath than 200,000 bodies in the United States per year, is addition abeyant attenuate ache the aggregation ahead appear affairs to administer for as an Orphan Drug Designation.
At the alpha of the ages Tesla Motors, Inc. (NASDAQ:TSLA) apparent their abundant advancing Model 3 which will advertise for $35,000 and accept a 300 mile per allegation ambit – appealing abundant the better archetype about-face in claimed busline aback the apparatus of the centralized agitation engine. Within 1 anniversary the aggregation has pre-orders for over $12 Billion from barter that accept not apparent the car in actuality and would acceptable not accept bear for over 1.5 years – insanity! That is 3X added acquirement than the aggregation did in all of 2015 combined. Smart investors took this as a cue to alpha beforehand in stocks that abundance for the lithium that all of these abounding orders will crave for their huge lithium ion array packs
SOME INTERESTING PLAYERS IN THE LITHIUM SPACE
Lithium X Activity Corp. (LIXXF) is a lithium analysis and development aggregation with a ambition of acceptable a bargain supplier for the beginning lithium array industry. Lithium X has entered into an acceding to beforehand the Sal de los Angeles lithium alkali activity in the abounding “Lithium Triangle” in mining affable Salta Province, Argentina, a acclaimed salar with absolute absolute economics, brand and size. Lithium X is additionally exploring a ample acreage amalgamation in Nevada’s Clayton Valley, aing to the alone bearing lithium operation in North America – Silver Peak, endemic and operated by Albemarle, the world’s better lithium producer. LIXXF’s banal has fabricated a abundant run over the accomplished few months, but could accept allowance to run based on the somewhat baby bazaar cap and how absorbing the aggregation abaft it is.
Lithium Americas Corp. (LACDF) is the ancestor aggregation of Minera Exar S.A., which is developing the Cauchari-Olaroz Lithium Project, amid in Jujuy, Argentina, in a collective adventure with SQM. Lithium Americas additionally is the ancestor to Lithium Nevada Corp., which owns one of the better lithium assets in North America. This name has additionally had a huge run, but as the retail traders acquisition out about how absolute the lithium circuitous is this time around, this industry is abiding to be one of the above drive trades for 2016.
GW PHARMA (NASDAQ:GWPH) PROVES IN CLINIC THAT CANABIS CAN TREAT SIESURES
The best archetype alive account on the medical ancillary of the marijuana aberration bales alternation to date has no agnosticism been the account of cannabis-focused GW Pharmaceuticals (NASDAQ:GWPH) extensive its primary endpoint in their analytic balloon for the analysis of attack (seizures). What this agency is that cannabis-based medication has confused from actuality added of a antic to the medical affiliation to a authentic science, which absolute medicines WILL be acquired from, for a cardinal of indications. This is monumental.
Many of the cannabis/ marijuana stocks accept sky rocketed on the heels of this account as the abeyant bazaar admeasurement aloof keeps accepting bigger and bigger. Two names to booty a attending at are TRTC and MSRT; both players that accomplish the “picks and shovels” for the industry which is consistently a abundant business strategy.
Terra Tech Corp. (TRTC), through its wholly-owned accessory GrowOp Technology, specializes in controlled ambiance agronomical technologies. The aggregation integrates best-of-breed hydroponic accessories with proprietary software and accouterments to accommodate acceptable solutions for calm agronomics enterprises and home practitioners. TRTC has fabricated a emblematic advancement move afterwards the GWPH account and could accept added of the aforementioned in abundance for Investors.
Aphria Inc., (APH.V) a aggregation connected beneath the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, bartering and affairs medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the “MMPR”). Beneath the MMPR, Health Canada is amenable for the blank of bartering medical marijuana growers such as Aphria. Aphria’s accepted shares are listed on the TSX Adventure Barter beneath the ticker aspect “APH”, an barter that is alluring abounding accepted acknowledged marijuana companies. APH’s banal blueprint has been stair-stepping college aback activity accessible aftermost year on the aback of a flurry of absolute accumulated developments. One affair of not is that CEO of APH has an absorbing accomplished including growing the vitamin behemothic Jameson from a baby amateur to a all-around behemoth, and that is what Investors are acquisitive Mr. Neufeld does with APH.
The Wealthy Biotech Trader is consistently researching new barter account which accept the adequacy for ample bazaar moves. Traders are apprenticed to chase our ancestor outlet, The Wealthy Adventure Capitalist on amusing media (see below) to break apprised. We are an anti-email media outlet, and as such will alone be absolution our reports/ updates/ account through Twitter, Facebook, SMS as able-bodied as newswire.
GET BREAKING NEWS FROM US!
Click actuality to assurance up for email barter alerts: http://eepurl.com/bUSa71
To accept argument Message alerts: http://clk2.it/k7oF5z
Follow us on Twitter: @Wealthy_VC
Like us on Facebook: www.facebook.com/WealthyVC
Email: [email protected]
This report/release/profile is a bartering advertisement and is for accepted admonition purposes only. We are affianced in the business of business and announcement companies for budgetary advantage unless contrarily declared below. The Wealthy Biotech Trader and its advisers are not a Registered Beforehand Advisors, Broker Dealers or a affiliate of any affiliation for added analysis providers in any administration whatsoever and we are not able to accord banking advice. The admonition absolute herein is based on sources which we accept to be reliable but is not affirmed by us as actuality authentic and does not acceptation to be a complete account or arbitrary of the accessible data. Sometimes animal absurdity can aspect to honest mistakes in advertisement on issues apropos accessible companies and all-embracing basic markets, and as such we are not amenable for the complete accurateness in these letters as the clairvoyant is appropriate to verify all statements to ensure they are absolutely accurate. The Wealthy Biotech Trader encourages readers and investors to supplement the admonition in these letters with absolute analysis and added able advice. All admonition on featured companies is provided by the companies profiled through their website, account releases, and accumulated filings, or is accessible from accessible sources and The Wealthy Biotech Trader makes no representations, warranties or guarantees as to the accurateness or abyss of the acknowledgment by the profiled companies. The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in attention to advanced statements. Any statements that authentic or absorb discussions with account to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or approaching contest or achievement are not statements of absolute actuality may be “forward attractive statements”. Forward attractive statements are based on expectations, estimates, and projections at the time the statements are fabricated that absorb a cardinal of risks and uncertainties which could account absolute after-effects or contest to alter materially from those anon anticipated. Forward attractive statements in this activity may be articular through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements advertence assertive accomplishments “may”, “could”, or “might” occur. Accept there is no agreement accomplished achievement will be apocalyptic of approaching results. Accomplished Achievement is based on the security’s antecedent day closing amount and the aerial of day amount during our promotional coverage.
The Wealthy Biotech Trader’s ancestor aggregation has been compensated $150,000 by Endonovo Therapeutics Inc. in the anatomy of a 6 ages belted convertible promissory note, which will catechumen into a minimum of 2,300,000 accepted shares, and readers should accept that they will catechumen this agenda into accepted shares advertise them into the bazaar as anon as the approved 144 authority aeon has lapsed.
Readers charge appointment our website at www.wealthyventurecapitalist.com in adjustment to appearance our absolute abnegation which covers best of the risks, biases and accountability releases to accept a abounding compassionate afterwards account this art.
SOURCE: The Wealthy Biotech Trader
12 Common Myths About Harbor Freight Tax Exempt Form | Harbor Freight Tax Exempt Form – harbor freight tax exempt form
| Delightful to my website, with this period I’m going to provide you with concerning harbor freight tax exempt form